Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
5/4/26 Oncolytics Biotech (ONC) pelareorep for Colorectal Cancer (CRC) Subscribers Only Subscribers Only Subscribers Only
4/30/26 AstraZeneca (AZN) camizestrant for HR+/HER2- Breast Cancer Subscribers Only Subscribers Only Subscribers Only
4/30/26 AstraZeneca (AZN) Truqap for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only
4/27/26 Compass Therapeutics (CMPX) tovecimig for Biliary Tract Cancer Subscribers Only Subscribers Only Subscribers Only
4/27/26 Mundipharma Rezzayo for Fungal Infections - Systemic Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update